Highlights and Quick Summary
- Cash per Share for the quarter ending June 30, 2023 was 1.75 (a -79.61% decrease compared to previous quarter)
- Year-over-year quarterly Cash per Share decreased by -63.82%
- Annual Cash per Share for 2022 was 12.83 (a 19.07% increase from previous year)
- Annual Cash per Share for 2021 was 10.77 (a -8.66% decrease from previous year)
- Annual Cash per Share for 2020 was 11.79 (a 261.52% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash per Share of Emergent Biosolutions Inc.
Most recent Cash per Shareof EBS including historical data for past 10 years.Interactive Chart of Cash per Share of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Cash per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 1.75 | 8.57 | – | – | – |
| 2022 | 12.83 | 4.83 | 7.17 | 8.6 | 12.83 |
| 2021 | 10.77 | 7.52 | 8.35 | 10.28 | 10.77 |
| 2020 | 11.79 | 7.83 | 5.11 | 3.49 | 11.79 |
| 2019 | 3.26 | 2.7 | 3.45 | 2.68 | 3.26 |
| 2018 | 2.24 | 6.79 | 3.83 | 3.32 | 2.24 |
| 2017 | 4.29 | 8.3 | 7.7 | 6.63 | 4.29 |
| 2016 | 6.75 | 7.39 | 8.29 | 8.62 | 6.75 |
| 2015 | 7.99 | 7.95 | 5.58 | 5.71 | 7.99 |
| 2014 | 7.51 | 6.46 | 4.49 | 4.35 | 7.51 |
| 2013 | 4.95 | 4.76 | 4.32 | 3.62 | 4.95 |
| 2012 | 3.93 | 5.47 | – | – | 3.93 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic